Monthly Archives: October 2015

E

Shares of Five Prime Therapeutics (FPRX) are up 62% after entering into a collaboration agreement with Bristol-Myers (BMY). Both companies entered into this agreement to collaborate on Five Prime’s anti-body program for the treatment of cancer. Five Prime is receiving an upfront payment of $350 million for this collaboration.  The upfront payment for Five Prime…

Strengthening Yen

Just a very quick “before I walk my dogs” post: the USD/JPY continues to break down, as the Japanese Yen (amazingly enough) strengthens. I think people will be surprised at how strong the Yen behaves in the months ahead.

Goldman Suffers Terrible Quarter After FICC, Prop Trading Revenue

Once again, Jefferies’ one-month early glimpse at Wall Street trading revenues proved to be spot on. After the boutique mid-market banks reported a total collapse in fixed income trading revenues (which ended up negative following massive charge offs), everyone was looking at the biggest hedge fund among the TBTF banks – Goldman Sachs – to see just…

Guide To Middle East ETF Investing

Investing in the Middle East stock market might look to be daunting at this moment when the price of crude oil, which accounts for the lion’s share of the region’s revenues, continues to plunge and is currently trading near its six-year low. Geopolitical tension and depleting foreign reserves are some of the other issues disturbing…

Blackstone Misses Estimates, U.S. Bancorp In Line

Blackstone (BX) and U.S. Bancorp (USB)  released their third quarter earnings reports before opening bell this morning. U.S. Bancorp posted earnings of 81 cents per share, which was in line with consensus, on $5.15 billion in revenue, which was slightly ahead of the $5.12 billion analysts had been looking for. Blackstone posted economic net losses…